MetLife Investment Management’s CorVel CRVL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.08M | Buy |
17,231
+630
| +4% | +$36.7K | ﹤0.01% | 1491 |
|
|
2026
Q1 | $907K | Sell |
16,601
-146
| -0.9% | -$8.41K | ﹤0.01% | 1450 |
|
|
2025
Q4 | $1.13M | Sell |
16,747
-620
| -4% | -$44.9K | 0.01% | 1355 |
|
|
2025
Q3 | $1.34M | Hold |
17,367
| – | – | 0.01% | 1292 |
|
|
2025
Q2 | $1.78M | Buy |
17,367
+1,596
| +10% | +$176K | 0.01% | 1048 |
|
|
2025
Q1 | $1.77M | Sell |
15,771
-279
| -2% | -$31.1K | 0.01% | 1098 |
|
|
2024
Q4 | $1.79M | Buy |
16,050
+669
| +4% | +$74.9K | 0.01% | 1103 |
|
|
2024
Q3 | $1.68M | Hold |
15,381
| – | – | 0.01% | 1117 |
|
|
2024
Q2 | $1.3M | Buy |
15,381
+2,097
| +16% | +$173K | 0.01% | 1204 |
|
|
2024
Q1 | $1.16M | Sell |
13,284
-828
| -6% | -$66.6K | 0.01% | 1216 |
|
|
2023
Q4 | $1.16M | Hold |
14,112
| – | – | 0.01% | 1224 |
|
|
2023
Q3 | $925K | Hold |
14,112
| – | – | 0.01% | 1266 |
|
|
2023
Q2 | $910K | Hold |
14,112
| – | – | 0.01% | 1314 |
|
|
2023
Q1 | $895K | Sell |
14,112
-651
| -4% | -$38K | 0.01% | 1269 |
|
|
2022
Q4 | $715K | Hold |
14,763
| – | – | 0.01% | 1406 |
|
|
2022
Q3 | $681K | Hold |
14,763
| – | – | 0.01% | 1410 |
|
|
2022
Q2 | $725K | Hold |
14,763
| – | – | 0.01% | 1409 |
|
|
2022
Q1 | $829K | Buy |
14,763
+5,277
| +56% | +$300K | 0.01% | 1449 |
|
|
2021
Q4 | $658K | Hold |
9,486
| – | – | 0.01% | 1348 |
|
|
2021
Q3 | $589K | Hold |
9,486
| – | – | 0.01% | 1437 |
|
|
2021
Q2 | $425K | Hold |
9,486
| – | – | ﹤0.01% | 1668 |
|
|
2021
Q1 | $324K | Sell |
9,486
-3,315
| -26% | -$115K | ﹤0.01% | 1769 |
|
|
2020
Q4 | $452K | Hold |
12,801
| – | – | ﹤0.01% | 1533 |
|
|
2020
Q3 | $365K | Hold |
12,801
| – | – | ﹤0.01% | 1535 |
|
|
2020
Q2 | $302K | Hold |
12,801
| – | – | ﹤0.01% | 1647 |
|
|
2020
Q1 | $233K | Hold |
12,801
| – | – | ﹤0.01% | 1609 |
|
|
2019
Q4 | $373K | Hold |
12,801
| – | – | ﹤0.01% | 1618 |
|
|
2019
Q3 | $323K | Hold |
12,801
| – | – | ﹤0.01% | 1661 |
|
|
2019
Q2 | $371K | Sell |
12,801
-25,602
| -67% | -$630K | ﹤0.01% | 1657 |
|
|
2019
Q1 | $835K | Buy |
38,403
+25,602
| +200% | +$547K | ﹤0.01% | 1762 |
|
|
2018
Q4 | $263K | Buy |
12,801
+2,496
| +24% | +$50.9K | ﹤0.01% | 1756 |
|
|
2018
Q3 | $207K | Sell |
10,305
-5,670
| -35% | -$109K | ﹤0.01% | 2058 |
|
|
2018
Q2 | $288K | Hold |
15,975
| – | – | ﹤0.01% | 1733 |
|
|
2018
Q1 | $269K | Hold |
15,975
| – | – | ﹤0.01% | 1738 |
|
|
2017
Q4 | $282K | Buy |
+15,975
| New | +$301K | ﹤0.01% | 1745 |
|
Other funds holding CRVL
MetLife Investment Management's CRVL Position: Q2 2026 in Review
MetLife Investment Management increased its CorVel (CRVL) stake by 3.8% in Q2 2026, buying an estimated $36.7K and bringing the position to 17,231 shares worth $1.08M. The position accounts for ﹤0.01% of the portfolio, ranked #1491.
MetLife Investment Management first reported a position in CRVL in Q4 2017 and has held it in 35 quarters since. The position peaked at $1.79M in Q4 2024. 290 funds tracked by Wall St. Rank hold CRVL as of Q2 2026.
- MetLife Investment Management held 17,231 shares of CorVel worth $1.08M as of Q2 2026.
- MetLife Investment Management bought 630 CorVel shares in Q2 2026, an estimated $36.7K.
- CorVel made up ﹤0.01% of MetLife Investment Management's portfolio in Q2 2026, its #1491 holding.
- MetLife Investment Management first reported a position in CorVel in Q4 2017 and has held it in 35 quarters since.
- MetLife Investment Management's CorVel position peaked at $1.79M in Q4 2024.
- 290 funds tracked by Wall St. Rank held CorVel as of Q2 2026.
Based on MetLife Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.